大和:重申藍月亮(6993.HK)買入評級 目標價17.4港元
大和發表研究報吿表示,重申藍月亮(6993.HK)買入評級及目標價17.4港元,按2021年度市盈率55倍計算,該行予集團的目標市盈率倍數較同業高出約10%,反映集團專注於快速增長的產品及其在電子商務市場中的強大實力。
該行表示,集團管理層強調,投入成本增加會為毛利率帶來壓力,不過,在2016至17年的上一次商品成本上升週期中,集團仍能將其毛利率維持在60%以上。該行相信,集團會採取適當措施令均價在下半年有上調空間。另外,在更多的線上銷售活動的支持下,管理層預期,下半年的收入增長將進一步加快。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.